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Abstract
Cellular redox status and membrane protein activities were analyzed in kidneys from rats with ischemic acute renal failure
(ARF). ARF was induced by clamping the left renal artery for 50 min. A parallel group of control animals was processed. In
the ischemic group urea plasma levels were statistically increased as compared with the control group. Studies employing
whole kidney homogenates revealed that ischemia produces an increment in lipid peroxidation levels and a reduction in
glutathione concentration and in superoxide dismutase and glutathione peroxidase activities. Since lipid peroxidation may
alter the function of membrane proteins we determined succinate cytochrome c reductase (SuccR), sodium-potassium
ATPase (Na-K-ATPase), glucose-6-phosphatase (G-6-Pase) and alkaline phosphatase (ALP) activities in whole renal
homogenates. Only G-6-Pase and ALP activities were modified by ischemia. Since ALP is a brush border membrane (BBM)
enzyme and BBM is one of the main target structures in ARF, we assessed some parameters of BBM functionality. ALP,
Q-glutamyl transferase (Q-GT) and 5P-nucleotidase (5P-NT) showed diminished activities in BBM from ischemic kidneys.
Ischemia also modified the Vmax of paraaminohippuric acid (PAH) uptake without altering Km. An increment of lipid
peroxidation and membrane fluidity in BBM was observed after the treatment. Total membrane proteins and protein
recoveries in BBM were similar in both experimental groups. Sialic acid and sulfhydryl levels were similar in BBM from
ischemic kidney and control ones. In summary, ARF induced by renal artery clamping for 50 min takes place with a
significant increase in urea plasma levels. A decrease in the antioxidant defense system is detected. This induces lipid
peroxidation in whole renal tissue, which may justify the diminished activities of some membrane enzymes such as G-6-Pase
and ALP. A specific analysis of BBM function reveals a significant increment of lipid peroxidation which may be the cause of
an increased membrane fluidity. This latter parameter might be, at least in part, responsible for the damaged function of
apical ALP, 5P-NT, Q-GT and PAH carrier. ß 1998 Elsevier Science B.V. All rights reserved.
Keywords: Ischemia; Acute renal failure; Membrane enzyme; Antioxidant defense system; Paraaminohippuric acid uptake; Brush
border membrane vesicle; Membrane £uidity; Lipid peroxidation
1. Introduction
Ischemic injury occurs when a reduction in blood
£ow decreases the delivery of oxygen and substrates
to a level inadequate to maintain cellular energy sta-
tus. Cellular depletion of ATP, the initial pathophys-
iologic event and hallmark of ischemic injury, leads
to a series of morphologic, biochemical and physio-
logic derangements [1,2]
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Renal ischemia is a major cause of acute renal
failure (ARF). Ischemic renal failure occurs follow-
ing an episode of severe hemorrhagic shock, endo-
toxic sepsis, thermal burns, or transplantation sur-
gery [3,4].
The ARF syndrome is characterized by the rap-
id (hours to weeks) decline of the glomerular ¢l-
tration rate and the retention of nitrogenous waste
products such as blood urea nitrogen (BUN) and
creatinine. The measure of these products is likely
to remain as the principal method of ARF diagnosis
[5^7].
The proximal tubule is the primary site and the
most susceptible to cellular damage induced by ische-
mia. The most sensitive cell to in vivo ischemic injury
in the kidney has been shown to be in the S3 segment
[6,8]. The most extensively studied ARF model is
provided by total cessation of renal blood £ow (typ-
ically by renal artery clamping). This model de¢nes
the multiple factors that may potentially contribute
to the pathophysiology of ischemic renal injury,
which makes it a very valuable tool. This work pur-
sued the following goals:
1. to obtain an experimental model of an early stage
of ischemic ARF which may be clinically detected
by an increment of BUN. The left renal artery of
the rat was clamped during di¡erent periods of
time and BUN was measured simultaneously.
2. to further characterize the mechanisms responsible
for ischemia induced injury of epithelial cells in
this model. In order to achieve this, we analyzed
the following items in renal cortical tissue:
2.1. redox cellular status in whole homogenates:
thiobarbituric acid reactive species (TBARS),
glutathione concentrations (GSH); superox-
ide dismutase (SOD), glutathione peroxidase
(GSH-Px) and catalase (CAT) activities.
2.2. activity of some membrane enzymes in whole
homogenates: succinate cytochrome c reduc-
tase (SuccR), sodium-potassium ATPase (Na-
K-ATPase), glucose-6-phosphatase (G-6-
Pase) and alkaline phosphatase (ALP).
2.3. function of brush border membranes (one of
the primary sites of ischemia induced cellular
injury [6,8]) by assaying:
b protein function: e.g. enzyme activities: al-
kaline phosphatase (ALP), Q-glutamyl
transferase (Q-GT), 5P-nucleotidase (5P-
NT) and transport of paraaminohippuric
acid (PAH)
b lipid function assayed as lipid peroxidation
levels and membrane £uidity
b in order to obtain preliminary evidence
about the quality of proteins inserted in
brush border membrane, sialic acid and
sulfhydryl contents were assayed.
2. Materials and methods
Male Wistar rats (110^130 days old) weighing
300^350 g were used throughout the study. Animals
were allowed free access to a standard laboratory
chow and tap water, and housed in a constant tem-
perature and humidity environment.
Animals were anesthetized with sodium thiopental
(70 mg/kg b.w., i.p.). In order to select an adequate
time to induce acute ischemia, a non-traumatic vas-
cular clamp was placed around the left renal artery
for 0, 10, 20 and 50 min. To avoid re£ows, the clamp
was left in place until the kidney was removed. After
this procedure, a blood sample was obtained by car-
diac puncture in order to determine plasma urea lev-
els. Once 50 min was selected as the optimal time to
induce acute renal failure, kidneys were excised and
divided for: (a) histopathology studies, (b) assess-
ment of GSH and TBARS levels and enzyme activ-
ities (SOD, GSH-Px, CAT, SuccR, Na-K-ATPase,
G-6-Pase, ALP); (c) studies with brush border mem-
brane vesicles (BBMV). BBMV were employed to
determine enzyme activities (ALP, Q-GT, 5P-NT),
PAH transport studies, TBARS levels, £uorescence
polarization studies, sialic acid and sulfhydryl con-
tent. A parallel group of control rats was also proc-
essed.
2.1. Histopathological studies
Histopathology of kidneys was performed after
¢xing in 4% neutral bu¡ered formalin for 2 and 4 h
and embedding in para⁄n, then 4 Wm thick sections
were processed for routine staining with hematoxylin
and eosin.
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2.2. Assessment of GSH and TBARS levels and en-
zyme activities
In order to analyze GSH and TBARS levels and
enzyme activities, kidney cortices were cut o¡ (n = 4
for the control group and n = 6 for the ischemic
group) and homogenized in 30 volumes (w/v)
250 mM sucrose, 10 mM HEPES-Tris (pH 7.40).
Determination of non-protein sulfhydryl (95%
GSH) was performed as described by Ellman [9].
TBARS were quantitated according to the method
of Ohkawa et al. [10]. Malondialdehyde (MDA), an
end product of lipid peroxidation, reacts with thio-
barbituric acid (TBA) to yield a colored substance.
Measurement of MDA by TBA is one of the most
widely used methods for assessing lipid peroxides.
SOD activity was assayed by its ability to inhibit
superoxide radical dependent reactions [11]. The re-
duction rate of cytochrome c by superoxide radicals
was monitored at 550 nm using the xanthine-xan-
thine oxidase system as the source of superoxide rad-
ical. One unit of SOD is de¢ned as the amount of
SOD in the homogenate required to inhibit 50% of
the rate of cytochrome c reduction.
GSH-Px was assayed by continuous monitoring of
GSSG formation. GSSG formed during the gluta-
thione peroxidase reaction was instantly and contin-
uously reduced by an excess of glutathione reductase
activity providing for a constant level of GSH. The
concomitant oxidation of NADPH was monitored
photometrically [12]. The rate of change of absorb-
ance during the conversion of NADPH to NADP
was recorded at 340 nm for 5 min. GSH-Px activity
was expressed as Wmol of NADPH oxidized to
NADP/min/mg protein.
CAT activity measurement was based on the titri-
metric determination of H2O2 with KMnO4 [13]. The
activity is expressed as k/min/mg protein, where k is
the ¢rst order rate constant.
SuccR was measured spectrophotometrically at
30‡C by following the reduction of cytochrome c at
550 nm [14].
Na-K-ATPase activity was estimated as the di¡er-
ence between the amounts of inorganic phosphate
released in the absence (total ATPase) and in the
presence (Mg-ATPase) of ouabain [15].
G-6-Pase activity was measured as described by
Sottocasa et al. [14].
ALP activity was assayed employing a Wiener
commercial kit.
The release of inorganic phosphate was measured
according to Widnell et al. [16]. Proteins were ana-
lyzed by the method of Smith et al. [17].
2.3. Studies with brush border membrane vesicles
2.3.1. Preparation of brush border membrane vesicles
from kidney cortex
BBMV were isolated from renal cortex by Mg/
EGTA precipitation as described by Ohoka et al.
[18]. The BBMV obtained were resuspended in
250 mM sucrose, HEPES-Tris 10 mM, pH 7.40. Ali-
quots of the membranes were frozen in liquid nitro-
gen and stored immediately at 370‡C until use. Three
preparations were made for the control group and
three for the ischemic group. Each preparation repre-
sented the left renal cortical tissues from six animals.
2.3.2. Enzyme assays
The purity of BBMV preparation was monitored
by measuring the speci¢c activity of ALP, SuccR,
G-6-Pase, and Na-K-ATPase as described above.
Q-GT activity in BBMV was determined kinetically
at 405 nm employing Q-glutamyl-p-nitroanilide as
substrate using a commercial kit (Q-GT Test, Wiener
Lab, Argentina). 5P-NT activity in BBMV was also
assayed employing a Wiener commercial kit.
2.3.3. PAH transport studies
PAH uptake by BBMV was measured by the rapid
¢ltration technique using a Millipore vacuum ¢ltra-
tion system and nitrocellulose membranes with a
pore size of 0.45 Wm (HAWP 0.24, Millipore, Bed-
ford, MA, USA) as reported by Ohoka et al. [18]. All
¢lters were soaked and presaturated overnight in
1 mM unlabelled PAH in 100 mM NaCl, 1 mM
HEPES-Tris, pH 7.40 to minimize non-speci¢c bind-
ing of radioactivity. The degree of non-speci¢c bind-
ing to the ¢lter was about 0.02%. BBMV were rap-
idly thawed at 37‡C and preincubated in 100 mM
sucrose, 100 mM K-gluconate, 10 mM HEPES-Tris
pH 7.40 at 37‡C for 1 h. The reaction was started by
adding 25 Wl of vesicles (125^200 Wg protein) to 300 Wl
of incubation medium at 37‡C. The medium con-
tained (mM) 100 sucrose, 100 K-gluconate,
10 HEPES-Tris, pH 7.40, 10 WCi 3H-PAH to which
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unlabelled PAH was added to yield ¢nal concentra-
tions. After a predetermined incubation time, the
uptake was terminated by diluting the samples to
1.0 ml with ice-cold stop solution (150 mM KCl,
20 mM HEPES-Tris pH 7.40). The diluted samples
were immediately ¢ltered, then the ¢lters were
washed three times with 3 ml ice-cold stop solution.
Radioactivity in the ¢lters was measured in a liquid
scintillation spectrometer counter. Uptake at time
zero was assessed by simultaneously mixing 1 ml of
cold stop solution with 25 Wl of membranes and
300 Wl of the isotope-containing bu¡er. The diluted
sample was immediately ¢ltered and washed three
times with 3 ml of stop solution. The ‘uptake’ at
time zero was subtracted from that obtained at the
same PAH concentration after incubating at 37‡C
during a predetermined incubation time.
2.3.4. Fluorescence polarization measurements in
BBMV
The £uidity of brush border membranes was as-
sessed by measuring the steady-state £uorescence ani-
sotropy of 1,6-diphenyl-1,3,5-hexatriene (DPH)
[19,20]. DPH was dissolved in tetrahydrofuran at a
concentration of 1 mM and diluted 1000-fold in
10 mM HEPES-Tris pH 7.40. BBMV (270 Wg pro-
tein) were incubated for 1 h at 25‡C with DPH (¢nal
concentration 1 WM). The DPH was excited at
366 nm and emission was observed at 433 nm at
25‡C. The £uorescence anisotropy was calculated us-
ing the equation r = (IN3GIP/IN+2GIP) where IN and
IP are the £uorescence intensities observed with the
polarized light emitted parallel and perpendicular,
respectively, to the excitation polarizer. G is the cor-
rection factor for the optical system, given by the
ratio of vertically to horizontally polarized emission
components when the excitation light is polarized in
the horizontal direction [21].
2.3.5. Sialic acid content in BBMV
Sialic acid was quantitated employing the thiobar-
bituric assay [22]. The color of the chromophore ob-
tained was intensi¢ed by the addition of dimethyl
sulfoxide [23]. The exposed sialic acid were assayed
before and after the treatment with Triton X-100.
2.3.6. Measurement of sulfhydryl content in BBMV
The membranes (0.1 mg protein/ml) were incu-
bated with 10 mM 5,5P-dithiobis (2-nitrobenzoate)
(DTNB) in 50 mM Tris-HCl bu¡er (pH 8.0) for
10 min at 37‡C in the presence of 3% SDS. The
amount of DTNB-reactive SH groups was deter-
mined using the molar extinction coe⁄cient of
1.36U104 M31 cm31 at 412 nm [9].
2.3.7. Others determinations
TBARS levels in BBMV were assayed as described
above. Proteins were also analyzed by the method of
Smith et al. [17].
2.4. Materials
Chemicals were purchased from Sigma (St. Louis,
MO, USA) and were analytical grade pure. 3H-PAH
was obtained from DuPont-New England Nuclear.
2.5. Statistical analysis
The results are expressed as means þ S.E.M. The
comparison between the control and ischemic groups
was made using the unpaired t-test. P6 0.05 was
regarded as statistically signi¢cant. The results ob-
tained with BBMV are expressed as means þ S.D.
of at least three di¡erent experiments performed in
at least three di¡erent vesicle preparations for each
experimental group. Kinetic data were ¢tted by the
Michaelis-Menten model with a non-linear, least
square criterion using the Enz¢tter program (Elsevier
Biosoft).
Fig. 1. Urea plasma levels 0, 10, 20 and 50 min post left renal
artery clamping.
BBADIS 61734 22-7-98
G. Montagna et al. / Biochimica et Biophysica Acta 1407 (1998) 99^108102
3. Results
Fig. 1 shows urea plasma levels after di¡erent pe-
riods of left renal artery clamping. Only after 50 min
of ischemia was a statistically increment in this pa-
rameter observed.
Histopathological studies revealed a corticomedul-
lary congestion and some subcapsular cytoplasmic
degeneration of proximal convoluted tubules in is-
chemic kidneys.
Fig. 2A shows that ischemic kidneys presented
higher levels of TBARS than control kidneys. Fig.
2B shows a signi¢cant decrease of GSH levels after
the treatment.
The activities of antioxidant enzymes SOD, GSH-
Px and CAT are summarized in Table 1. The ische-
mic situation caused a signi¢cant diminution in renal
SOD and GSH-Px activities. CAT activity was stable
in the face of the ischemic injury.
After the treatment no modi¢cations were ob-
served in SuccR and Na-K-ATPase (Fig. 3). ALP
and G-6-Pase activities in whole homogenates from
ischemic kidneys were statistically di¡erent from
those observed in the control group (Fig. 4).
Fig. 2. Thiobarbituric acid reactive species (TBARS, A) and
glutathione levels (GSH, B) in control (n = 4) and ischemic
(n = 6) kidneys. Results are expressed as means þ S.E.M.
#P6 0.05 control vs. ischemic group.
Table 1
Superoxide dismutase, glutathione peroxidase and catalase activities in control (n = 4) and ischemic (n = 6) kidneys
Superoxide dismutase
(U SOD/mg protein)
Glutathione peroxidase
(Wmol/min/mg protein)
Catalase
(k/min/mg protein)
Control kidneys 148 þ 13 2.14 þ 0.13 3.48 þ 0.69
Ischemic kidneys 108 þ 4* 1.08 þ 0.04* 3.85 þ 0.15
Results are expressed as means þ S.E.M.
*P6 0.05 control vs. ischemic group.
Fig. 3. (A) Succinate cytochrome c reductase (SuccR) activity
in control (n = 4) and ischemic (n = 6) kidneys. (B) Sodium-po-
tassium-ATPase (Na-K-ATPase) activity in control (n = 3) and
ischemic (n = 3) kidneys. Results are expressed as means þ
S.E.M.
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Table 2 summarizes the speci¢c activities and en-
richment of marker enzymes, in both the homoge-
nates and ¢nal brush border membrane isolated
from control and ischemic kidneys. The speci¢c ac-
tivity of ALP in the brush border membrane was 15-
fold higher than that in the homogenate in both ex-
perimental groups, indicating a similar purity of the
membranes. However, the speci¢c activity of ALP
was reduced in both the homogenate and brush bor-
der membrane from ischemic kidneys. Contamina-
tion of brush border membranes by intracellular or-
ganelles was not modi¢ed, but speci¢c activities of
G-6-Pase (microsomal marker) was reduced in ho-
mogenates from ischemic kidneys. Neither speci¢c
activity nor SuccR (mitochondrial marker) contami-
nation was altered by ischemia. No signi¢cant di¡er-
ence between the control and ischemic kidneys was
observed with regard to the speci¢c activities of Na-
K-ATPase in the homogenates and ¢nal brush bor-
der membrane. This agrees with the results of Maeda
et al. [24] and Kim et al. [25], but not with the data
reported by Molitoris et al. [26]. No di¡erences were
observed in total protein levels and protein recovery
between groups. This fact indicates no modi¢cation
in protein quantity after the treatment.
To estimate the relative proportion of right side
out vesicles the exposed sialic acid was assessed be-
fore and after treatment with Triton X-100. The ori-
entation of BBMV was 80 þ 1.3 and 78 þ 6.6% right
side out in the control and ischemic groups respec-
tively.
ALP, Q-GT and 5P-NT, marker enzymes of apical
membranes, were sensitive to blood £ow interruption
(Table 3).
Ischemia decreased the initial PAH uptake com-
pared to control (38 þ 5 vs. 77 þ 9 nmol PAH/mg
Fig. 4. Glucose-6-phosphatase (G-6-Pase, A) and alkaline phos-
phatase (ALP, B) activities in control (n = 4) and ischemic
(n = 6) kidneys. Results are expressed as means þ S.E.M.
#P6 0.05 control vs. ischemic group.
Table 2
Speci¢c activities and enrichment of marker enzymes in rat renal cortex homogenates and brush border membrane vesicles isolated
from control (C) and ischemic (Is) kidneys
Homogenates Vesicles Enrichment
Succinate cytochrome c reductase (nmol Cit/min/mg protein) C: 43 þ 2 C: 2.75 þ 0.68 C: 0.063 þ 0.012
Is: 49 þ 4 Is: 1.27 þ 0.09 Is: 0.026 þ 0.009
glucose-6-phosphatase (Wmol Pi/min/mg protein) C: 102 þ 2 C: 96 þ 7 C: 0.94 þ 0.08
Is: 56 þ 6* Is: 80 þ 6 Is: 1.43 þ 0.06
Na-K-ATPase (Wmol Pi/mg protein/h) C: 10.12 þ 1.28 C: 4.77 þ 1.66 C: 0.44 þ 0.10
Is: 6.31 þ 0.74 Is: 4.49 þ 3.52 Is: 0.62 þ 0.49
Alkaline phosphatase (mIU/mg protein) C: 265 þ 19 C: 3979 þ 232 C: 15.09 þ 0.78
Is: 173 þ 15* Is: 2590 þ 148* Is: 15.10 þ 0.80
Proteins (mg) C: 941 þ 111 C: 21.93 þ 1.89 C: 0.024 þ 0.002
Is: 856 þ 139 Is: 23.51 þ 4.00 Is: 0.027 þ 0.003
Results are expressed as means þ S.D. from experiments carried out in triplicate in at least three di¡erent vesicle preparations for each
experimental group.
*P6 0.05 control vs. ischemic group.
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protein per 15 s, respectively, P6 0.05). The time
course of 3H-PAH uptake by BBMV was determined
over a period of 30 min. The uptake rose to an equi-
librium plateau at 60 s and was constant thereafter in
both groups. Uptake velocity was linear up to 15 s in
the control group and up to 30 s in the ischemic
group. Accordingly, unless otherwise indicated, the
15 s time was chosen to measure PAH uptake to
ful¢ll the requirements for measuring linear trans-
port. A statistical diminution in the initial uptake
velocity up to 30 s was observed in ischemic
BBMV (Fig. 5A). To determine whether this e¡ect
of ischemia was due to an alteration in the substrate
Table 3
Alkaline phosphatase, Q-glutamyltransferase and 5P-nucleotidase activities in brush border membranes from control and ischemic kid-
neys
Alkaline phosphatase
(mIU/mg protein)
Q-Glutamyltransferase
(IU/mg protein)
5P-Nucleotidase
(mIU/mg protein)
Control kidneys 3979 þ 232 48 066 þ 2230 538 þ 36
Ischemic kidneys 2590 þ 148* 35 043 þ 677* 304 þ 14*
Results are expressed as means þ S.D. from experiments carried out in triplicate in at least three di¡erent vesicle preparations for each
experimental group.
*P6 0.05 control vs. ischemic group.
Fig. 5. PAH uptake in brush border membrane vesicles from
control (b) and ischemic (a) kidneys. (A) Time course of PAH
uptake. Membrane vesicles (25 Wl, 125^200 Wg of protein) were
incubated for di¡erent times (0.8 s^30 min) at 37‡C with 300 Wl
of incubation medium containing 2.63 mM 3H-PAH. (B) Ki-
netics of PAH uptake. Membrane vesicles (25 Wl, 125^200 Wg of
protein) were incubated for 15 s at 37‡C with 300 Wl of incuba-
tion medium containing di¡erent concentrations of 3H-PAH
(0.8^14 mM). Results are means þ S.D. from experiments car-
ried out in triplicate in at least three di¡erent vesicles prepara-
tions for each experimental groups.
Fig. 6. Thiobarbituric acid reactive species (TBARS, A) and
anisotropy values (r, B) in brush border membrane vesicles
from control and ischemic kidneys. Results are means þ S.D.
from experiments carried out in triplicate on at least three dif-
ferent vesicles preparations for each experimental group.
#P6 0.05 control vs. ischemic group.
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a⁄nity (Km) and/or the maximum velocity (Vmax) of
PAH transport, the initial rate (15 s) of PAH uptake
was measured as a function of the external PAH
concentrations (Fig. 5B). Ischemia decreased Vmax
as compared with control (160 þ 2 vs. 214 þ 16 nmol
PAH/mg protein per 15 s, respectively, P6 0.05). No
variations were observed for Km (mM) (4.93 þ 0.19
for the control group vs. 5.49 þ 0.58 for the ischemic
group).
Fig. 6 summarizes the e¡ects of ischemia on
TBARS and membrane £uidity in BBMV. Ischemia
increased both TBARS levels and membrane £uidity.
In order to have a preliminary assessment of pro-
tein quality, we measured sialic acid content (since
the negatively charged terminal sialic acid is an im-
portant residue of microvillus glycoproteins) and
sulfhydryl content in BBMV. Neither sialic acid
nor sulfhydryl residues changed with the treatment
(Table 4).
4. Discussion
Ischemia involves cessation of circulation to a tis-
sue so that metabolic substrates are not delivered
and metabolic products are not removed. Renal is-
chemia is a major cause of ARF. ARF by de¢nition
means acute impairment of renal excretory function
and is characterized by progressive azotemia [3^6]. In
this work we obtained an experimental model of an
early stage of ARF.
A number of processes have been implicated in the
pathogenesis of oxygen deprivation-induced cell in-
jury. These include disturbances of cell calcium me-
tabolism, disruption of the cytoskeleton, depletion of
adenine nucleotides, activation of phospholipases
with production of toxic lipid metabolites, loss of
cell volume and monovalent cation homeostasis
and generation of free radicals [5^8].
Tissue hypoxia favors the univalent reduction of
oxygen molecules that produces superoxide anions,
hydrogen peroxide and hydroxyl radicals [1,2]. The
main source of reactive oxygen species under hypoxic
conditions is the xanthine oxidase reaction [27^30].
To protect the cell against toxic oxygen metabolites,
there are several physiological defense mechanisms,
such as SOD, GSH-Px, CAT and the tripeptide GSH
[31,32]. The increment of TBARS in our experimen-
tal model, indicating the presence of lipid peroxida-
tion in the tissue, may be the consequence of an
increment in the formation of oxygen free radicals
(generated by the xanthine-xanthine oxidase system)
and/or an impairment of its metabolization since
antioxidant defense systems are compromised. In
this sense, it has been described that GSH-Px and
SOD can be inactivated by free radicals [33]. More-
over, GSH levels in our experimental model were
reduced as also described by others [34].
Lipid peroxidation results in the alteration of
membrane properties, such as enzyme activities, sol-
ute transport and £uidity [31,32]. We observed a re-
markable diminution of membrane enzymes activ-
ities, such as G-6-Pase and ALP, after ischemia.
With respect to this point, it has been reported that
altered membrane lipids from peroxidized micro-
somes are capable of inhibiting glucose 6-phospha-
tase [35].
Since ALP is a marker enzyme of the apical mem-
brane (one of the target structures for renal ischemic
injury [6,8,36]), we assessed the function of the brush
border membrane. The activity of other apical mem-
brane enzymes such as Q-GT and 5P-NT was also
decreased, in addition to ALP, in BBMV from ische-
mic kidneys. In this connection, other authors have
also reported a diminished activity of Q-GT and ALP
after ischemia [24^26]. The organic anion carrier that
has been described in brush border membrane trans-
ports many organic and inorganic anions such as
urate, lactate, PAH, OH3 and Cl3 [37]. We meas-
ured PAH uptake. The reduction in Vmax indicates a
diminution in the number of functional carrier units.
In this regard, it has been reported that ischemia
alters the transport properties of tetraethylammo-
nium and D-glucose in rat renal brush border mem-
branes [24,38]. Kim et al. [39] have reported that
Table 4
Sialic acid and sulfhydryl residue content in brush border mem-
brane vesicles isolated from control and ischemic kidneys
Sialic acid residues
(nmol/mg protein)
Sulfhydryl residues
(Wmol/mg protein)
Control kidneys 80 þ 3.69 3.29 þ 0.16
Ischemic kidneys 81 þ 4.36 3.64 þ 0.06
Results are expressed as means þ S.D. from experiments carried
out in triplicate in at least three di¡erent vesicle preparations
for each experimental group.
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tetraethylammonium but not PAH uptake in rabbit
brush border membranes was reduced following
60 min of ischemia.
The e¡ect of ischemia on the behavior of ALP, 5P-
NT, Q-GT and the organic anion carrier might be
explained by two possible mechanisms: alteration
in the transmembrane mobility of protein units due
to changes in the membrane lipid (composition and
contents) and/or reduction of the number of protein
units. We found a signi¢cant increment of TBARS
speci¢cally in BBMV from ischemic kidneys, indicat-
ing an increase of lipid peroxidation in these mem-
branes. In this regard, Fujimoto and Fujita [40] have
reported that lipid peroxidation alters PAH transport
in rat kidney. It has been described that lipid perox-
idation damages membrane £uidity [31,32,41]. In this
sense, we found a signi¢cant increase of brush border
membrane £uidity after ischemia. Membrane £uidity
has been shown to a¡ect numerous membrane func-
tions including passive permeability, enzymatic activ-
ities and transport systems [42]. This e¡ect can result
from a direct action on the conformational changes
required for the function of a given protein or may
involve the ease with which proteins associate or dis-
sociate [42,43]. On the other hand, Molitoris et al.
[26] postulated a selective loss of brush border mem-
brane proteins after ischemia. This fact would cause
a reduction in the number of protein units. In con-
trast, we obtained evidence for a conservation in
quality and quantity of protein content in renal ap-
ical membranes after 50 min of ischemia.
In summary, ARF induced by renal artery clamp-
ing during 50 min occurs with a signi¢cant increase
in urea plasma levels. A decrease in the antioxidant
defense system is found, which induces lipid perox-
idation in whole renal tissue. This may explain the
diminished activities of membrane enzymes such as
G-6-Pase and ALP. A speci¢c analysis of brush bor-
der membrane function reveals a signi¢cant incre-
ment of lipid peroxidation which might be the cause
of an increased membrane £uidity. This latter param-
eter might be, at least in part, responsible for the
damaged function of apical ALP, 5P-NT, Q-GT and
PAH carrier.
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